Quote Block Templates (55)

Fool Me Twice, Shame on Me: On the Wuhan Coronavirus Outbreak

As I was packing up on Friday, preparing myself for an unusually tiresome journey back to Ithaca totaling about three days on the road with three layovers, my phone buzzed: the U.S. Center for Disease Control announced that it would begin screening passengers arriving from Wuhan, China at Los Angeles, New York City, and San Francisco airports. Given my first layover in L.A.— lasting an unbelievably long twelve hours and giving me an excuse to visit Santa Monica for a bit— I was quite worried. For one, though I did not visit Wuhan this winter break, I was reminded of the panic after the West Africa Ebola epidemic back in 2013, when an overreaction caused a public health crisis in the United States, putting many African passengers under duress. Given the tense political climate between the U.S. and China, who knows there won’t be a repeat? A second, perhaps more foreboding concern, underlies my thoughts: Is the outbreak really this bad?

Quote Block Templates (54)

DERY | Return the Syllabus to Syllabus Week

Last semester, a friend and I enrolled in the same Freshman Writing Seminar, basing our decision on a brief course description in the Class Roster. We thought little of the fact that we enrolled in different sections; after all, not much else could differ besides the professor and time slot, right? Wrong. Yet, at the time, basking in our pre-freshman innocence, we were convinced otherwise — to the point where we promised each other we would be “study-buddies” when the semester rolled around. How cute.

(NYT18) UNDATED -- July 14, 2008 -- SCI-BRODY-HEALTH -- Photo Illustration. A Threat in a Grassy Stroll: Lyme Disease.  (Photo Illustration by Jez Burrows/The New York Times) *Only for use with NYT story entitled  SCI-BRODY-HEALTH. All other use prohibited.

Targeting Ticks: Cornell-Housed Company Designs New Lyme Disease Test

Dr. Joel Tabb and team at Ionica Sciences at Weill Cornell has developed a new and improved diagnostic test for Lyme disease. Unlike the current standard tests, that focus on the body’s immune response, Tabb’s test focuses on the disease causing bacteria itself and should be on the market by 2020.